Ter Tiero Elias Dah

Ter Tiero Elias Dah

Auto-generated profile, based on publicly available information

Ter Tiero Elias Dah

Association African Solidarité, Ouagadougou, Burkina Faso

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 August 2021 in AIDS
Verified
Journal Article
Open access
TDTer Tiero Elias Dah
Ter Tiero Elias Dah
IYIssifou YAYA
Issifou YAYA
EMEphrem Mensah
Ephrem Mensah
ACAlou Coulibaly
Alou Coulibaly
JKJean-Baptiste Malan Kouamé
Jean-Baptiste Malan Kouamé
CLChristian Laurent
Christian Laurent
Objective: To assess the time from HIV diagnosis to ART initiation and the effect of rapid ART initiation (i.e. within 7 days of HIV diagnosis) on attrition and virologic and immunologic responses among MSM in Burkina Faso, Côte d’Ivoire, Mali, and Togo. Design: Prospective cohort study between 2015 and 2019. Methods: MSM aged 18 years or older newly diagnosed with HIV infection were eligible to participate. ART was proposed to participants upon HIV diagnosis, irrespective of clinical stage and CD4+ cell count, and was initiated as soon as possible, with no specific time frame. Determinants of rapid ART initiation and its effect on treatment outcomes were assessed using multivariate analyses. Results: Of 350 MSM, 335 (95.7%) initiated ART after a median time of 5 days. Of the latter, 216 (64.5%) had rapid ART initiation. The 335 participants were followed up for a median time of 24.1 months. One hundred and eleven (33.1%) were not retained in care. Rapid ART initiation was less likely in participants with a CD4+ cell count at least 200 cells/μl [adjusted odds ratio (aOR) 0.37, 95% confidence interval (CI) 0.15–0.88]. It improved viral load suppression (aOR 6.96, 95% CI 1.98–24.46) but had no effect on attrition (aOR 0.87, 95% CI 0.57–1.33) or CD4+ cell count increase (adjusted coefficient 28.23, 95% CI −17.00 to 73.45). Conclusion: These results in MSM in West Africa support the WHO recommendation for rapid ART initiation. Clinics need to develop context-specific strategies for rapid ART initiation and for retaining MSM in HIV care. ClinicalTrials.gov, number NCT02626286.


28 October 2022 in Viruses
Verified
Journal Article
Open access
PDF file
AEAugust Eubanks
August Eubanks
BCBakary Coulibaly
Bakary Coulibaly
BKBintou Dembélé Keita
Bintou Dembélé Keita
CACamille Anoma
Camille Anoma
TDTer Tiero Elias Dah
Ter Tiero Elias Dah
TGthe CohMSM-PrEP Study Group
the CohMSM-PrEP Study Group
Loss to follow-up (LTFU) from HIV pre-exposure prophylaxis (PrEP) care compromises the goal of HIV elimination. We investigated the proportion of LTFU and associated risk factors among men who have sex with men (MSM) enrolled in a PrEP demonstration project in Burkina Faso, Côte d’Ivoire, Mali, and Togo. CohMSM-PrEP, a prospective cohort study, was conducted between November 2017 and June 2021 in community-based clinics. MSM aged 18 years or older at substantial risk of HIV infection received a comprehensive prevention package, including PrEP and peer education. LTFU was defined as not returning to the clinic for six months. Associated risk factors were investigated using a time-varying Cox’s model. Of 647 participants followed up for a median time of 15 months, 372 were LTFU (57.5%). LTFU was associated with younger age (adjusted hazard ratio [95% Confidence Interval]; 1.50 [1.17–1.94]), unemployment (1.33 [1.03–1.71]), depression (1.63 [1.12–2.38]), and perceiving no HIV risk with stable male partners (1.61 [1.23–2.10]). Contacting peer educators outside of scheduled visits was protective (0.74 [0.56–0.97]). Our findings show that LTFU from PrEP care in West African MSM is a major challenge to achieving HIV elimination, but that the involvement of peer educators in PrEP delivery helps to limit LTFU by providing users with adequate support.

22 May 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
OGon behalf of the CohMSM Study Group
on behalf of the CohMSM Study Group
TDTer Tiero Elias Dah
Ter Tiero Elias Dah
IYIssifou YAYA
Issifou YAYA
LSLuis Sagaon-Teyssier
Luis Sagaon-Teyssier
ACAlou Coulibaly
Alou Coulibaly
CLChristian Laurent
Christian Laurent
Background: Access to tailored HIV prevention services remains limited for West African MSM. We assessed adherence to quarterly HIV prevention services and its impact on HIV incidence in MSM followed up in four cities in Burkina Faso, Côte d’Ivoire, Mali, and Togo.Methods: We performed a prospective cohort study between 2015 and 2018. HIV-negative MSM aged over 18 benefited from quarterly medical visits which included a clinical examination, HIV testing, screening and treatment for other sexually transmitted infections, peer-led counselling and support, and the provision of condoms and lubricants. Determinants of adherence to quarterly follow-up visits and incident HIV infections were identified using generalized estimating equation models and Cox proportional hazard models, respectively.Results: 618 MSM were followed up for a median time of 20.0 months (interquartile range 15.2–26.3). Overall adherence to quarterly follow-up visits was 76.5% (95% confidence interval [CI] 75.1–77.8), ranging from 66.8% in Abidjan to 87.3% in Lomé (p < 0.001). 78 incident HIV infections occurred during a total follow-up time of 780.8 person-years, giving an overall incidence of 10.0 per 100 person-years (95% CI 8.0–12.5). Adherence to quarterly follow-up visits was not associated with the risk of incident HIV infection (adjusted hazard ratio 0.80, 95% CI 0.44–1.44,p = 0.545).Conclusions: Strengthening HIV prevention services among MSM in West Africa, including the use of PrEP, will be critical for controlling the epidemic, not only in this key population but also in the general population. Quarterly follow-up of MSM, which is essential for PrEP delivery, appears feasible.Trial registration: ClinicalTrials.gov, numberNCT02626286(December 10, 2015).

23 May 2019 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
TDTer Tiero Elias Dah
Ter Tiero Elias Dah
CCClotilde Couderc
Clotilde Couderc
ACAlou Coulibaly
Alou Coulibaly
MKMalan Jean-Baptiste Kouamé
Malan Jean-Baptiste Kouamé
MAMawuényégan Kouamivi Agboyibor
Mawuényégan Kouamivi Agboyibor
CLChristian Laurent
Christian Laurent
Although men who have sex with men (MSM) are at high risk of hepatitis B virus (HBV) infection, they do not have access to vaccination in West Africa, which is a highly endemic region. We investigated HBV prevalence and associated factors, as well as acceptability and difficulties of vaccination in MSM enrolled in an operational research program in Burkina Faso, Côte d’Ivoire, Mali, and Togo. We followed up 779 MSM in 2015–2018. Participants who were negative for both hepatitis B surface antigen (HBsAg) and antibodies (anti-HBs) at enrollment were offered HBV vaccination. Factors associated with HBV infection were identified using logistic regression models. Overall, HBV prevalence was 11.2% (95% confidence interval [CI], 9.0%–13.6%). It was lower in Togo than in Côte d’Ivoire (2.7% vs 17.3%; adjusted odds ratio [aOR], 0.12; 95% CI, 0.02–0.28) and higher in participants with 6+ recent male sexual partners (21.0% vs 9.3%; aOR, 1.48; 95% CI, 1.12–1.97). Of 528 participants eligible for vaccination, 484 (91.7%) were willing to be vaccinated and received at least 1 dose (ranging from 68.2% in Abidjan to 96.4% in Bamako; P < .001). Of the latter, 390 (80.6%) received 3 or 4 doses. The proportion of participants for whom the minimum required time between each dose was respected ranged from 10.9% in Bamako to 88.6% in Lomé (P < .001). MSM in West Africa should be targeted more for HBV screening and vaccination. Although vaccination is well accepted by MSM, greater training of health care workers and education of MSM are required.

14 May 2025 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
GOGorik Ooms
Gorik Ooms
YAYibeltal Assefa
Yibeltal Assefa
SCSalome Charalambous
Salome Charalambous
TDTer Tiero Elias Dah
Ter Tiero Elias Dah
KDKristof Decoster
Kristof Decoster
RRRaffaella Ravinetto
Raffaella Ravinetto